Breaking News Instant updates and real-time market news.

TA

TravelCenters

$86.16 /

+0.095 (+0.11%)

, ARKO

Arko Corp.

$8.48 /

+0.235 (+2.85%)

13:05
03/29/23
03/29
13:05
03/29/23
13:05

Arko says 'riskless' to TravelCenters' holders for board to engage on proposal

ARKO Corp. (ARKO) issued a letter to TravelCenters of America's (TA) board, setting forth additional details of ARKO's financing in connection with its proposal to acquire TravelCenters, and again asking for TravelCenters' engagement with ARKO in the sale process. The letter discloses a second amendment to ARKO's Standby Real Estate Purchase, Designation and Lease Program agreement with Oak Street, a Division of Blue Owl Capital, in which Oak Street has agreed, subject to the terms contained in the Program Agreement, to provide for an additional $1.25B of capacity specifically to finance ARKO's acquisition of TravelCenters. "In addition to the additional capacity provided by the amended Program Agreement, ARKO has significant additional liquidity through cash, cash equivalents, and availability under its existing credit lines. ARKO has never required any financing conditions and has closed every acquisition it has put under contract. ARKO's proposal to TravelCenters offers no financing-related conditions. TravelCenters' Board has refused to engage at all with ARKO since ARKO originally submitted, on March 14, 2023, a superior proposal of $92 a share, a nearly 7% premium to the $86 per share price pursuant to TravelCenters' existing merger agreement with BP Products North America Inc., a wholly owned indirect subsidiary of BP p.l.c. ARKO's proposal was further improved on March 27, 2023, including ARKO's willingness to pre-pay $202 million for 11 years of lease payments, using the same discount rate as BP's proposal, in comparison to BP's proposal to pre-pay $188 million for 10 years of lease payments. ARKO believes it is riskless to TravelCenters' stockholders for TravelCenters' Board to engage with ARKO, and that doing so could reasonably be expected to lead to a superior proposal. ARKO has retained financial and legal advisors for this transaction and believes this update merits immediate engagement by TravelCenters's Board, management, and advisors... ARKO's track record, strong financial position, and confidence in obtaining financing for this transaction should be seriously considered by TravelCenters' Board and management when assessing whether ARKO's superior proposal is in the best interests of TravelCenters' stockholders. ARKO is prepared to immediately commence confirmatory due diligence and quickly enter into an Agreement and Plan of Merger along with the other ancillary arrangements on the same material terms as in the Merger Agreement with BP," the company stated in a press release.

TA

TravelCenters

$86.16 /

+0.095 (+0.11%)

ARKO

Arko Corp.

$8.48 /

+0.235 (+2.85%)

BP

BP

$37.66 /

+0.23 (+0.61%)

OTHER BREAKING NEWS FROM THE FLY

Initiation
iRhythm assumed with an Overweight at Morgan Stanley » 06:58
05/30/23
05/30
06:58
05/30/23
06:58
IRTC

iRhythm

$119.31 /

-1.51 (-1.25%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:58

Get Free Trial

ShowHide Related Items >><<
IRTC iRhythm
$119.31 /

-1.51 (-1.25%)

IRTC iRhythm
$119.31 /

-1.51 (-1.25%)

05/05/23 Canaccord
iRhythm price target raised to $153 from $143 at Canaccord
05/05/23 Needham
iRhythm price target raised to $151 from $133 at Needham
05/05/23 Citi
iRhythm price target raised to $135 from $130 at Citi
04/17/23 Truist
iRhythm price target raised to $154 from $137 at Truist
IRTC iRhythm
$119.31 /

-1.51 (-1.25%)

IRTC iRhythm
$119.31 /

-1.51 (-1.25%)

Initiation
Axonics assumed with an Overweight at Morgan Stanley » 06:58
05/30/23
05/30
06:58
05/30/23
06:58
AXNX

Axonics

$48.52 /

-1.03 (-2.08%)

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:58

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$48.52 /

-1.03 (-2.08%)

AXNX Axonics
$48.52 /

-1.03 (-2.08%)

05/23/23 CL King
Axonics initiated with Buy on 'underpenetrated markets' at CL King
05/23/23 CL King
Axonics initiated with a Buy at CL King
05/02/23 Needham
Axonics price target raised to $73 from $71 at Needham
04/17/23 Truist
Axonics price target lowered to $73 from $82 at Truist
AXNX Axonics
$48.52 /

-1.03 (-2.08%)

  • 03
    Aug
AXNX Axonics
$48.52 /

-1.03 (-2.08%)

Recommendations
Insperity price target lowered to $120 from $131 at Baird » 06:57
05/30/23
05/30
06:57
05/30/23
06:57
NSP

Insperity

$110.43 /

+0.2 (+0.18%)

Baird analyst Mark Marcon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:57

Get Free Trial

ShowHide Related Items >><<
NSP Insperity
$110.43 /

+0.2 (+0.18%)

NSP Insperity
$110.43 /

+0.2 (+0.18%)

04/27/23 Roth MKM
Insperity price target raised to $147 from $144 at Roth MKM
04/24/23 Truist
Insperity cut to Hold at Truist amid softening white collar labor trends
04/24/23 Truist
Insperity downgraded to Hold from Buy at Truist
04/24/23 Truist
Insperity downgraded to Hold from Buy at Truist
NSP Insperity
$110.43 /

+0.2 (+0.18%)

NSP Insperity
$110.43 /

+0.2 (+0.18%)

Initiation
Sight Sciences assumed with an Overweight at Morgan Stanley » 06:57
05/30/23
05/30
06:57
05/30/23
06:57
SGHT

Sight Sciences

$9.26 /

+0.24 (+2.66%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:57

Get Free Trial

ShowHide Related Items >><<
SGHT Sight Sciences
$9.26 /

+0.24 (+2.66%)

SGHT Sight Sciences
$9.26 /

+0.24 (+2.66%)

01/06/23 Stifel
Stifel upgrades Sight Sciences to Buy on potential 2023 upside
01/06/23 Stifel
Sight Sciences upgraded to Buy from Hold at Stifel
12/12/22 Citi
Sight Sciences price target raised to $15 from $10 at Citi
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
SGHT Sight Sciences
$9.26 /

+0.24 (+2.66%)

SGHT Sight Sciences
$9.26 /

+0.24 (+2.66%)

Initiation
Insulet assumed with an Equal Weight at Morgan Stanley » 06:56
05/30/23
05/30
06:56
05/30/23
06:56
PODD

Insulet

$272.56 /

-4.225 (-1.53%)

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:56

Get Free Trial

ShowHide Related Items >><<
PODD Insulet
$272.56 /

-4.225 (-1.53%)

PODD Insulet
$272.56 /

-4.225 (-1.53%)

05/08/23 Barclays
Insulet price target raised to $329 from $292 at Barclays
05/05/23 UBS
Insulet price target raised to $360 from $328 at UBS
05/05/23 Piper Sandler
Insulet price target raised to $360 from $340 at Piper Sandler
05/05/23 Baird
Insulet price target raised to $370 from $350 at Baird
PODD Insulet
$272.56 /

-4.225 (-1.53%)

PODD Insulet
$272.56 /

-4.225 (-1.53%)

PODD Insulet
$272.56 /

-4.225 (-1.53%)

Initiation
DexCom assumed with an Equal Weight at Morgan Stanley » 06:56
05/30/23
05/30
06:56
05/30/23
06:56
DXCM

DexCom

$115.06 /

+0.475 (+0.41%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:56

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$115.06 /

+0.475 (+0.41%)

DXCM DexCom
$115.06 /

+0.475 (+0.41%)

05/01/23 Barclays
DexCom price target raised to $115 from $110 at Barclays
04/28/23 Stifel
DexCom price target raised to $140 from $130 at Stifel
04/28/23 UBS
DexCom price target raised to $150 from $142 at UBS
04/28/23 BTIG
DexCom price target raised to $134 from $132 at BTIG
DXCM DexCom
$115.06 /

+0.475 (+0.41%)

DXCM DexCom
$115.06 /

+0.475 (+0.41%)

DXCM DexCom
$115.06 /

+0.475 (+0.41%)

DXCM DexCom
$115.06 /

+0.475 (+0.41%)

Initiation
TransMedics assumed with an Equal Weight at Morgan Stanley » 06:55
05/30/23
05/30
06:55
05/30/23
06:55
TMDX

TransMedics

/

+

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:55

Get Free Trial

ShowHide Related Items >><<
TMDX TransMedics
/

+

TMDX TransMedics
/

+

05/18/23 Canaccord
TransMedics price target lowered to $86 from $91 at Canaccord
05/02/23 Oppenheimer
TransMedics price target raised to $90 from $85 at Oppenheimer
05/01/23 Canaccord
TransMedics price target raised to $91 from $78 at Canaccord
02/23/23 Canaccord
TransMedics price target raised to $78 from $68 at Canaccord
TMDX TransMedics
/

+

  • 05
    Aug
TMDX TransMedics
/

+

Recommendations
Hibbett price target lowered to $50 from $70 at Baird » 06:55
05/30/23
05/30
06:55
05/30/23
06:55
HIBB

Hibbett

$39.20 /

-4.9 (-11.11%)

Baird lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:55

Get Free Trial

ShowHide Related Items >><<
HIBB Hibbett
$39.20 /

-4.9 (-11.11%)

HIBB Hibbett
$39.20 /

-4.9 (-11.11%)

05/26/23 Baird
Hibbett price target lowered to $50 from $80 at Baird
05/26/23 BofA
Hibbett downgraded to Underperform from Buy at BofA
05/26/23 Williams Trading
Hibbett cut to Sell at Williams Trading after 'far worse' than expected outlook
05/26/23 Williams Trading
Hibbett downgraded to Sell from Hold at Williams Trading
HIBB Hibbett
$39.20 /

-4.9 (-11.11%)

HIBB Hibbett
$39.20 /

-4.9 (-11.11%)

Initiation
Teleflex assumed with an Equal Weight at Morgan Stanley » 06:54
05/30/23
05/30
06:54
05/30/23
06:54
TFX

Teleflex

$232.54 /

-0.87 (-0.37%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:54

Get Free Trial

ShowHide Related Items >><<
TFX Teleflex
$232.54 /

-0.87 (-0.37%)

TFX Teleflex
$232.54 /

-0.87 (-0.37%)

04/26/23 Wolfe Research
Teleflex downgraded to Peer Perform from Outperform at Wolfe Research
04/18/23 Mizuho
Teleflex price target raised to $250 from $220 at Mizuho
04/17/23 Truist
Teleflex price target raised to $264 from $250 at Truist
12/28/22 Stephens
Teleflex price target raised to $295 from $280 at Stephens
TFX Teleflex
$232.54 /

-0.87 (-0.37%)

Initiation
Edwards Lifesciences assumed with an Overweight at Morgan Stanley » 06:54
05/30/23
05/30
06:54
05/30/23
06:54
EW

Edwards Lifesciences

$82.00 /

+0.32 (+0.39%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:54

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

05/18/23 Truist
Edwards Lifesciences price target raised to $101 from $97 at Truist
04/28/23 Barclays
Edwards Lifesciences price target raised to $102 from $94 at Barclays
04/27/23 Wells Fargo
Edwards Lifesciences price target raised to $90 from $78 at Wells Fargo
04/27/23 Piper Sandler
Edwards Lifesciences price target raised to $83 from $80 at Piper Sandler
EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

EW Edwards Lifesciences
$82.00 /

+0.32 (+0.39%)

Initiation
ShockWave Medical assumed with an Equal Weight at Morgan Stanley » 06:53
05/30/23
05/30
06:53
05/30/23
06:53
SWAV

ShockWave Medical

/

+

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:53

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
/

+

SWAV ShockWave Medical
/

+

05/12/23 Piper Sandler
Piper continues to view ShockWave Medical as 'highly coveted asset'
05/09/23 Deutsche Bank
ShockWave Medical price target raised to $310 from $285 at Deutsche Bank
05/09/23 Needham
ShockWave Medical price target raised to $325 from $283 at Needham
05/09/23 Piper Sandler
ShockWave Medical price target raised to $315 from $280 at Piper Sandler
SWAV ShockWave Medical
/

+

SWAV ShockWave Medical
/

+

SWAV ShockWave Medical
/

+

Recommendations
Lincoln Electric price target raised to $200 from $184 at Baird » 06:53
05/30/23
05/30
06:53
05/30/23
06:53
LECO

Lincoln Electric

$173.52 /

+2.76 (+1.62%)

Baird analyst Mircea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:53

Get Free Trial

ShowHide Related Items >><<
LECO Lincoln Electric
$173.52 /

+2.76 (+1.62%)

LECO Lincoln Electric
$173.52 /

+2.76 (+1.62%)

05/02/23 Barclays
Lincoln Electric price target raised to $185 from $145 at Barclays
04/28/23 Oppenheimer
Lincoln Electric price target raised to $180 from $177 at Oppenheimer
04/27/23 Baird
Lincoln Electric price target raised to $184 from $180 at Baird
04/17/23 Stifel
Lincoln Electric price target raised to $176 from $173 at Stifel
LECO Lincoln Electric
$173.52 /

+2.76 (+1.62%)

Initiation
Boston Scientific assumed with an Overweight at Morgan Stanley » 06:52
05/30/23
05/30
06:52
05/30/23
06:52
BSX

Boston Scientific

$51.05 /

-0.49 (-0.95%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:52

Get Free Trial

ShowHide Related Items >><<
BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

05/16/23 BofA
BofA says Boston Scientific Watchman label update important, ups target
04/27/23 Stifel
Boston Scientific price target raised to $58 from $52 at Stifel
04/27/23 RBC Capital
Boston Scientific price target raised to $56 from $53 at RBC Capital
04/27/23 Deutsche Bank
Boston Scientific price target raised to $55 from $45 at Deutsche Bank
BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

BSX Boston Scientific
$51.05 /

-0.49 (-0.95%)

Initiation
Bausch + Lomb assumed with an Equal Weight at Morgan Stanley » 06:52
05/30/23
05/30
06:52
05/30/23
06:52
BLCO

Bausch + Lomb

$17.92 /

-0.58 (-3.14%)

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:52

Get Free Trial

ShowHide Related Items >><<
BLCO Bausch + Lomb
$17.92 /

-0.58 (-3.14%)

BLCO Bausch + Lomb
$17.92 /

-0.58 (-3.14%)

05/22/23 Jefferies
Bausch Health price target raised to $9.50 from $7 at Jefferies
05/19/23 H.C. Wainwright
Bausch + Lomb price target raised to $22 from $19 at H.C. Wainwright
05/18/23 Wells Fargo
Bausch + Lomb has 'significant opportunity' with Miebo, says Wells Fargo
05/17/23 RBC Capital
District Court ruling positive for Bausch Health and Bausch + Lomb, says RBC
BLCO Bausch + Lomb
$17.92 /

-0.58 (-3.14%)

BLCO Bausch + Lomb
$17.92 /

-0.58 (-3.14%)

Initiation
Alcon assumed with an Equal Weight at Morgan Stanley » 06:51
05/30/23
05/30
06:51
05/30/23
06:51
ALC

Alcon

$79.06 /

+0.78 (+1.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:51

Get Free Trial

ShowHide Related Items >><<
ALC Alcon
$79.06 /

+0.78 (+1.00%)

ALC Alcon
$79.06 /

+0.78 (+1.00%)

05/24/23 Barrington
Lifecore price target raised to $10 from $8 at Barrington
05/23/23 Stephens
Lifecore 'now a much cleaner story,' says Stephens
05/11/23 JPMorgan
Alcon price target raised to CHF 71 from CHF 63.80 at JPMorgan
05/11/23 Mizuho
Alcon price target raised to $95 from $85 at Mizuho
ALC Alcon
$79.06 /

+0.78 (+1.00%)

ALC Alcon
$79.06 /

+0.78 (+1.00%)

Recommendations
Google AI chip orders accelerating at Broadcom, says JPMorgan » 06:50
05/30/23
05/30
06:50
05/30/23
06:50
AVGO

Broadcom

$812.72 /

+84.07 (+11.54%)

, GOOG

Alphabet

$125.37 /

+1.04 (+0.84%)

, GOOGL

Alphabet

$124.62 /

+1.14 (+0.92%)

, META

Meta Platforms

$262.01 /

+9.33 (+3.69%)

JPMorgan analyst Harlan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:50

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

06:11 Today KeyBanc
Broadcom price target raised to $820 from $720 at KeyBanc
05/26/23 Oppenheimer
Broadcom price target raised to $800 from $720 at Oppenheimer
05/25/23 BofA
Nvidia price target raised to $450 from $340 at BofA
05/25/23 Susquehanna
Broadcom price target raised to $785 from $690 at Susquehanna
GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

06:11 Today KeyBanc
Broadcom price target raised to $820 from $720 at KeyBanc
05/24/23 BofA
Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA
05/24/23 BofA
Partnership with Waymo 'positive for Uber on several fronts,' says BofA
05/23/23 Jefferies
Alphabet price target raised to $150 from $130 at Jefferies
GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

06:11 Today KeyBanc
Broadcom price target raised to $820 from $720 at KeyBanc
05/24/23 BofA
Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA
05/24/23 BofA
Partnership with Waymo 'positive for Uber on several fronts,' says BofA
05/23/23 Jefferies
Alphabet price target raised to $150 from $130 at Jefferies
META Meta Platforms
$262.01 /

+9.33 (+3.69%)

05/23/23 Piper Sandler
Meta's AI initiatives could drive revenue recapture, says Piper Sandler
05/23/23 Citi
Citi sees minimal risk to Meta Platforms after E.U. data fine
05/22/23 Evercore ISI
Meta, Spotify, Zillow removed from 'Tactical Outperform' list at Evercore ISI
05/19/23 Roth MKM
Meta Platforms' capex may decline in 2023-2024, says Roth MKM
AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

AVGO Broadcom
$812.72 /

+84.07 (+11.54%)

GOOG Alphabet
$125.37 /

+1.04 (+0.84%)

GOOGL Alphabet
$124.62 /

+1.14 (+0.92%)

META Meta Platforms
$262.01 /

+9.33 (+3.69%)

Hot Stocks
Pfizer's marstacimab shows significant efficacy in Phase 3 hemophilia trial » 06:49
05/30/23
05/30
06:49
05/30/23
06:49
PFE

Pfizer

$37.59 /

-0.245 (-0.65%)

Pfizer announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:49

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$37.59 /

-0.245 (-0.65%)

PFE Pfizer
$37.59 /

-0.245 (-0.65%)

05/23/23 Jefferies
Jefferies says Pfizer oral GLP-1 safety and tolerability 'important to note'
05/22/23
Pfizer weight loss drug may be as effective, quicker than Ozempic, CNBC says
05/19/23 BofA
AdComm support for Pfizer's infant RSV vaccine 'not surprising,' says BofA
05/16/23 Stifel
Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel
PFE Pfizer
$37.59 /

-0.245 (-0.65%)

PFE Pfizer
$37.59 /

-0.245 (-0.65%)

PFE Pfizer
$37.59 /

-0.245 (-0.65%)

PFE Pfizer
$37.59 /

-0.245 (-0.65%)

Initiation
Baxter assumed with an Equal Weight at Morgan Stanley » 06:48
05/30/23
05/30
06:48
05/30/23
06:48
BAX

Baxter

$41.29 /

-0.055 (-0.13%)

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48

Get Free Trial

ShowHide Related Items >><<
BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

05/01/23 Barclays
Baxter price target raised to $58 from $54 at Barclays
04/28/23 Stifel
Baxter price target raised to $54 from $45 at Stifel
04/28/23 Deutsche Bank
Baxter price target raised to $50 from $40 at Deutsche Bank
04/28/23 TD Cowen
Baxter price target raised to $50 from $45 at TD Cowen
BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

Initiation
Becton Dickinson assumed with an Overweight at Morgan Stanley » 06:48
05/30/23
05/30
06:48
05/30/23
06:48
BDX

Becton Dickinson

$241.13 /

-0.49 (-0.20%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

05/08/23 Barclays
Becton Dickinson price target raised to $284 from $282 at Barclays
05/05/23 Piper Sandler
Becton Dickinson upgraded to Overweight after pullback at Piper Sandler
05/05/23 Piper Sandler
Becton Dickinson upgraded to Overweight from Neutral at Piper Sandler
04/12/23 KeyBanc
Becton Dickinson upgraded to Overweight from Sector Weight at KeyBanc
BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

Hot Stocks
Team regains NYSE compliance » 06:47
05/30/23
05/30
06:47
05/30/23
06:47
TISI

Team

$8.10 /

+1.08 (+15.38%)

Team announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:47

Get Free Trial

ShowHide Related Items >><<
TISI Team
$8.10 /

+1.08 (+15.38%)

Hot Stocks
Golden Minerals to effect 1-for-25 reverse stock split » 06:46
05/30/23
05/30
06:46
05/30/23
06:46
AUMN

Golden Minerals

/

+

Golden Minerals announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:46

Get Free Trial

ShowHide Related Items >><<
AUMN Golden Minerals
/

+

AUMN Golden Minerals
/

+

03/24/23 Alliance Global Partners
Golden Minerals price target lowered to 80c from $1.10 at Alliance Global
08/04/22 H.C. Wainwright
Golden Minerals price target lowered to 60c from $1 at H.C. Wainwright
Recommendations
PayPal recent weakness should be bought, says Mizuho » 06:45
05/30/23
05/30
06:45
05/30/23
06:45
PYPL

PayPal

$60.22 /

+0.835 (+1.41%)

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:45

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

05/22/23 Bernstein
PayPal price target lowered to $70 from $85 at Bernstein
05/19/23 Morgan Stanley
Morgan Stanley says proposed 1099-K legislation 'incremental positive' for Block
05/12/23 Exane BNP Paribas
PayPal downgraded to Neutral from Outperform at Exane BNP Paribas
05/11/23 Barclays
PayPal price target lowered to $92 from $108 at Barclays
PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

Recommendations
Lantheus selloff on competitor approval overdone, says Mizuho » 06:42
05/30/23
05/30
06:42
05/30/23
06:42
LNTH

Lantheus

$91.06 /

-6.855 (-7.00%)

Mizuho views…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:42

Get Free Trial

ShowHide Related Items >><<
LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

05/05/23 SVB Securities
Lantheus price target raised to $127 from $120 at SVB Securities
05/05/23 Truist
Lantheus price target raised to $125 from $115 at Truist
05/05/23 JMP Securities
Lantheus price target raised to $130 from $120 at JMP Securities
05/05/23 Mizuho
Lantheus price target raised to $125 from $115 at Mizuho
LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

Recommendations
Omega Healthcare price target lowered to $31 from $32 at Mizuho » 06:39
05/30/23
05/30
06:39
05/30/23
06:39
OHI

Omega Healthcare

$28.34 /

+0.25 (+0.89%)

Mizuho analyst Vikram…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39

Get Free Trial

ShowHide Related Items >><<
OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

05/03/23 Stifel
Omega Healthcare price target lowered to $33 from $36 at Stifel
04/19/23 Wells Fargo
Omega Healthcare initiated with an Overweight at Wells Fargo
01/13/23 Baird
Omega Healthcare price target lowered to $29 from $32 at Baird
01/09/23 Credit Suisse
Omega Healthcare downgraded to Underperform from Neutral at Credit Suisse
OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

Recommendations
Ventas price target lowered to $53 from $60 at Mizuho » 06:39
05/30/23
05/30
06:39
05/30/23
06:39
VTR

Ventas

$42.87 /

+0.045 (+0.11%)

Mizuho analyst Vikram…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39

Get Free Trial

ShowHide Related Items >><<
VTR Ventas
$42.87 /

+0.045 (+0.11%)

VTR Ventas
$42.87 /

+0.045 (+0.11%)

04/25/23 Barclays
Ventas price target lowered to $55 from $57 at Barclays
04/19/23 Wells Fargo
Wells Fargo starts Ventas with Overweight on senior housing growth
04/19/23 Wells Fargo
Ventas initiated with an Overweight at Wells Fargo
04/12/23 Credit Suisse
Ventas price target lowered to $50 from $51 at Credit Suisse
VTR Ventas
$42.87 /

+0.045 (+0.11%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.